New Market Study Published: Digestive Remedies in the US
2012 was another turbulent year for digestive remedies. McNeil's ongoing manufacturing quality issues led to unpredictable or non-existent availability of such popular heartburn and indigestion brands as Pepcid, Mylanta and Rolaids, as well as previously dominant paediatric indigestion brand Mylicon. In addition, the company was compelled to initiate another recall of Imodium AD diarrhoeal remedies in May 2012 due to a packaging issue. Meanwhile, Novartis struggled with production failures of...
View full press release